Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions.
52W Range
64thpctl
Volume
0.70×avg
Market Cap
3.09BUSD
P/E Ratio
-65.8TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Tarsus Pharmaceuticals, Inc.
TARSNASDAQ Global Select·USD·Closed
Tarsus Pharmaceuticals, Inc.
TARSNASDAQ·USD·Closed
$71.76
−0.22%
$71.76
−$0.16 (0.22%)
52W Range
64thpctl
Volume
0.70×avg
Mkt Cap
3.09BUSD
P/E
-65.8TTM
Div Yield
–ann
TARS: Tarsus Pharmaceuticals, Inc. Stock Analysis | finqOS
